| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tuhura Biosciences, Inc./nv (HURA) has 2 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. HURA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 610.3K | $1.45M | - | |
| CFO | 273.7K | $651.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 5, 2017 | Praill Scott | Chief Financial Officer | Buy | 17,500 | $0.85 | $14,910.00 | +58.6% | |
| Jun 26, 2017 | Praill Scott | Chief Financial Officer | Buy | 4,167 | $3.60 | $15,001.20 | +16.5% | |
| Jun 26, 2017 | Bacha Jeffrey | CEO | Buy | 6,700 | $3.60 | $24,120.00 | +14.4% | |
| Jun 26, 2017 | Bell John K | Director | Buy | 4,167 | $3.60 | $15,001.20 | +9.2% | |
| Jun 26, 2017 | Cranston Lynda Sarah | Director | Buy | 2,083 | $3.60 | $7,498.80 | +798.1% | |
| Jun 26, 2017 | Mohr Erich | Director | Buy | 4,167 | $3.60 | $15,001.20 | +214.5% | |
| Jun 6, 2017 | Praill Scott | Chief Financial Officer | Buy | 9,500 | $2.10 | $19,950.00 | +60.2% | |
| Jun 6, 2017 | Bacha Jeffrey | CEO | Buy | 5,000 | $2.12 | $10,600.00 | +12.0% | |
| Jun 6, 2017 | Bell John K | Director | Buy | 10,000 | $2.12 | $21,200.00 | +28.3% | |
| May 5, 2017 | Bacha Jeffrey | Chief Executive Officer | Buy | 2,500 | $2.20 | $5,500.00 | +6.4% |